APR 18, 2017 7:10 AM PDT

A Drug for Overactive Bladder is Linked to Depression

Overactive bladder, or OAB, is common in elderly women but two recent research studies show that the most commonly prescribed drugs to treat it could have mental side effects. OAB is a condition where the urge to urinate is more frequent and more urgent than normal. While this can happen after childbirth, trauma or as a side effect of certain medications, it can and often does happen without any pathology or explanation. The National Overactive Bladder Evaluation (NOBLE) program estimates that it affects about 16% of women in the United States. Prevalence increases with age. A common class of drugs called antimuscarinics is usually prescribed for this condition but these medications are not without problems.

Antimuscarinics work by blocking muscarinic acetylcholine receptors in the brain. Acetylcholine (often abbreviated ACh) is a neurotransmitter whose receptor is the muscarinic protein found in synapses and other cell membranes. There has to be a balance in the brain of the neurotransmitter Ach and the protein receptors. When the ratios are disrupted, OAB can be the result. It’s interesting to note that this process is also involved in the regulation of dopamine in the brain, and disruption in that process is seen in Parkinson’s disease and in some forms of dementia.

The first study, from researchers at Taipei Medical University Hospital, used data from the Taiwan Longitudinal Health Insurance Database. The team there, led by Li-Ting Kao identified 1,952 women with OAB who took antimuscarinics and 9,760 women with OAB who did not take antimuscarinics. The women were followed for three years. Over this time period the patients who had taken the antimuscarinics had a 38% higher chance of being diagnosed with depressive disorder than those who had not taken the medication. The study was not exhaustive however. Some previous research at other universities showed some results similar to those of the team and in Taipei while other projects showed no correleation, Dr. Kao explained in a press “This population-based retrospective cohort study found that use of antimuscarinics was associated with subsequent depressive disorder in women with overactive bladder. We recommend that clinicians be alert to the relationship between antimuscarinics and depressive disorder in OAB women. In addition, clinicians can provide appropriate instructions for OAB women who receive antimuscarinics to seek health and medical services as soon as possible if they have relevant clinical symptoms of depressive disorder. However, future experimental studies are still required to identify the potential mechanisms for the association between antimuscarinic use and depressive disorder in OAB women.”

RELATED: Depression and Daylight Saving Time

Limits to the study included the ethnicity of the women. Since the data was pulled from a longitudinal study that included only Chinese women, it can’t be ruled out that there is a genetic or ethnic component. In addition, it only looked at women who had OAB symptoms and depression symptoms serious enough to seek medical treatment. Because both conditions can be embarrassing, many women will not bring either one up with their health care providers unless they are severe. Women who had only mild bladder symptoms or mild depressive symptoms, may not have reported them. The video below talks about the study in more detail, but since both depression and OAB can affect women at later stages in life, it’s important to know that there could be a connection between a medication for one and the prevalence of the other.

Sources: Clinical PharmacologyUPIUrology Care Foundation

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
NOV 04, 2019
Neuroscience
NOV 04, 2019
The Key to Living Longer is REST
  Scientists at Harvard Medical School show new evidence that the key to living longer is to get plenty of sleep.   The researchers were mapping ...
NOV 19, 2019
Cell & Molecular Biology
NOV 19, 2019
New Insight Into Chronic Pain May Help Create Novel Therapeutics
Acute pain can progress to chronic pain, which can cause other problems including depression, loss of motivation and sensory dysfunction....
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
DEC 12, 2019
Health & Medicine
DEC 12, 2019
Holiday Sweets May Trigger Depression
While it may be the most wonderful time of the year filled with an abundance of sweet treats, new research cautions those prone to depression to put that c...
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti...
DEC 20, 2019
Neuroscience
DEC 20, 2019
Hand-Motion Center of the Brain Involved in Speech
During a long-term study focused on improving computer-assistant interfaces for quadriplegia patients, researchers at Stanford University were able to use...
Loading Comments...